Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Mulgirigama, D. Hunt, R. Wilson, J. Pepke-Zaba (Tadworth, Papworth Everard, United Kingdom). A slower life in a smaller world. Patients‘ perspective on living with pulmonary arterial hypertension. Eur Respir J 2012; 40: Suppl. 56, 966

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary arterial hypertension: the burden of disease and impact on quality of life Source: Eur Respir Rev 2015; 24: 621-629 Year: 2015 Pulmonary arterial hypertension among elderly patients: an emerging problem? Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 The study of risk in pulmonary arterial hypertension Source: Eur Respir Rev 2012 21:234-238 Year: 2012 Everyday life experiences of spouses of patients who suffer from pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension Source: ERJ Open Res, 5 (1) 00218-2018; 10.1183/23120541.00218-2018 Year: 2019 Impact of pulmonary arterial hypertension (PAH) on the lives of patients and carers Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm Source: Eur Respir J 2015; 46: 299-302 Year: 2015 Assessment of quality of life and social and economic impact of the disease in patients with pulmonary arterial hypertension in Germany – Data of the SANTANA-Study Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Pregnancy outcomes in pulmonary arterial hypertension in the modern management era}, Source: Eur Respir J 2012; 40: 881-885 Year: 2012 The changing landscape of pulmonary arterial hypertension and implications for patient care Source: Eur Respir Rev 2014; 23: 450-457 Year: 2014 The assessment of life expectancy of patients with primary pulmonary hypertension (PPH) Source: Eur Respir J 2003; 22: Suppl. 45, 582s Year: 2003 Measurement of quality of life in pulmonary hypertension and its significance Source: Eur Respir J 2006 Oct 01;28(4):808-815 Year: 2006 Relationship of quality of life and life expectancy with tolerance to physical exercises and cardio respiratory parameters in patients with pulmonary arterial hypertension Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Patients‘, relatives‘ and practitioners‘ views on pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012 The obesity paradox in pulmonary arterial hypertension: the Scottish perspective Source: ERJ Open Res, 5 (4) 00241-2019; 10.1183/23120541.00241-2019 Year: 2019 Understanding the impact of pulmonary arterial hypertension on patients' and carers' lives Source: Eur Respir Rev 2013; 22: 535-542 Year: 2013 Sildenafil improves health-related quality of life in pulmonary arterial hypertension (PAH) patients Source: Eur Respir J 2005; 26: Suppl. 49, 563s Year: 2005 End points in pulmonary arterial hypertension: the way forward Source: Eur Respir J 2004; 23: 947-953 Year: 2004 A decade of achievement in pulmonary arterial hypertension Source: Annual Congress 2012 - The European Respiratory Review: what's hot in pulmonary medicine Year: 2012 The patient tells it! The importance of patient's quality of life perception in pulmonary arterial hypertension risk assessment Source: Eur Respir J, 57 (2) 2004376; 10.1183/13993003.04376-2020 Year: 2021 Survival in pulmonary hypertension in Spain: insights from the Spanish registry}, Source: Eur Respir J 2012; 40: 596-603 Year: 2012